Home  |  News  |  Sitemap  |  Contact Us  |  Login
Advertise With Us
Latest Notification
  • banner1
  • banner2
  • banner3
  • banner4
  • banner5
  • banner6
  • banner7
banner11 banner22 banner33 banner44 banner45 banner46 banner47

 Adverse Cases


Back Reported Adverse Drug Reaction Cases
Mirtazapine and blood dyscrasias

Mirtazapine, an antidepressant, is an analogue of mianserin and, like mianserin, has been associated with reports of neutropenia and agranulocytosis.

Since 2001 when the drug was registered, blood dyscrasias in association with mirtazapine have been reported to ADRAC in 36 patients (21 males and 15 females, age range 29 to 94 years). These include 5 reports of agranulocytosis and a further 19 of neutropenia. The Committee has also received 7 reports of severe pancytopenia and 6 of thrombocytopenia. In 21 of the 36 reports, mirtazapine was the sole suspected drug. Median time to onset was 3 weeks (range 3 days to 6 months).

Two reports described fatal outcomes, one from pneumonia associated with neutropenia and another from haemorrhage due to thrombocytopenia. Recovery was documented in 19 cases, 11 had not recovered and the outcome remained unknown for the others at the time of reporting.

The Product Information for mirtazapine includes a special warning/precaution regarding the possibility of neutropenia and agranulocytosis and recommends that mirtazapine should be stopped and blood counts taken if the patient experiences symptoms such as fever, sore throat, stomatitis or other signs of infection.

On starting mirtazapine, patients should be warned of this rare but potentially life-threatening adverse reaction, informed of the symptoms of febrile neutropenia, and advised to report to their doctor promptly if symptoms develop.

tetracyclin 250mg tetracyclin jerawat tetracyclin 250mg
References:
Australian Adverse Drug Reactions Bulletin, Volume 26, Number 3, June 2007
dexamethason 1 5 mg dexamethason 1 5 mg dexamethason krople

Back


» Home
» Latest Notification
» New Drugs
» Import of Drugs
» Drug Prices
» Legislations
» Applications Forms
» Quackwatch
» Forms & Fees
» Licence Conditions
» Schedules
» Health, Pharma. Policies & Reports
» Ayurvedic
» Govt. Bodies
» Information Centre
» Directory
» Alert
» Regulatory News
» Research News
» News in Hindi
» Login
» Contact Us

Copyright © DrugsControl.org - Jaipur, INDIA. All Rights Reserved   |   Disclaimer   |   Sitemap

Site last updated: December 30, 1899 at